{"count": 6, "results": [{"_id": "26255154", "pmid": 26255154, "title": "Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin.", "journal": "Pharmacol Biochem Behav", "authors": ["Mansouri MT", "Khodayar MJ", "Tabatabaee A", "Ghorbanzadeh B", "Naghizadeh B"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/j.pbb.2015.08.002", "meta_date_publication": "2015 Oct", "meta_volume": "137", "meta_issue": "", "meta_pages": "38-43", "score": 50055.387, "text_hl": "-precipitated withdrawal signs (jumping and @<m>DISEASE_Body_Weight</m> @DISEASE_MESH:D001835 @@@body weight loss@@@). Also, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ at doses of 100 and 300mg/kg attenuated the expression of @CHEMICAL_Morphine @CHEMICAL_MESH:D009020 @@@morphine@@@-induced tolerance and dependence. ", "citations": {"NLM": "Mansouri MT, Khodayar MJ, Tabatabaee A, Ghorbanzadeh B, Naghizadeh B. Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin. Pharmacol Biochem Behav. 2015 Oct;137():38-43. PMID: 26255154", "BibTeX": "@article{26255154, title={Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin.}, author={Mansouri MT and Khodayar MJ and Tabatabaee A and Ghorbanzadeh B and Naghizadeh B}, journal={Pharmacol Biochem Behav}, volume={137}, pages={38-43}}"}}, {"_id": "23680591", "pmid": 23680591, "title": "Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.", "journal": "Int J Cardiol", "authors": ["Palus S", "von Haehling S", "Flach VC", "Tschirner A", "Doehner W", "Anker SD", "Springer J"], "date": "2013-10-09T00:00:00Z", "doi": "10.1016/j.ijcard.2013.04.150", "meta_date_publication": "2013 Oct 9", "meta_volume": "168", "meta_issue": "4", "meta_pages": "3412-8", "score": 50053.41, "text_hl": "CONCLUSION: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuated @<m>DISEASE_Body_Weight</m> @DISEASE_MESH:D001835 @@@loss of body weight@@@ as well as muscle mass and improved cardiac function leading to improved survival in this @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@CC@@@ model. ", "citations": {"NLM": "Palus S, von Haehling S, Flach VC, Tschirner A, Doehner W, Anker SD, Springer J. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. Int J Cardiol. 2013 Oct 9;168(4):3412-8. PMID: 23680591", "BibTeX": "@article{23680591, title={Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.}, author={Palus S and von Haehling S and Flach VC and Tschirner A and Doehner W and Anker SD and Springer J}, journal={Int J Cardiol}, volume={168}, number={4}, pages={3412-8}}"}}, {"_id": "8835365", "pmid": 8835365, "title": "Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.", "journal": "Pharmacol Toxicol", "authors": ["Oms P", "Assie N", "Bruniquel F", "Degryse AD", "van Haverbeke G", "Delhon A"], "date": "1995-12-01T00:00:00Z", "doi": "10.1111/j.1600-0773.1995.tb01048.x", "meta_date_publication": "1995 Dec", "meta_volume": "77", "meta_issue": "6", "meta_pages": "391-6", "score": 50051.13, "text_hl": "In @SPECIES_10026 @@@hamsters@@@ fed the standard diet, gastric administration of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (10 mg/kg/day) during 12 days was found to be lethal and to have hepatotoxic and nephrotoxic effects. ", "citations": {"NLM": "Oms P, Assie N, Bruniquel F, Degryse AD, van Haverbeke G, Delhon A. Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate. Pharmacol Toxicol. 1995 Dec;77(6):391-6. PMID: 8835365", "BibTeX": "@article{8835365, title={Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.}, author={Oms P and Assie N and Bruniquel F and Degryse AD and van Haverbeke G and Delhon A}, journal={Pharmacol Toxicol}, volume={77}, number={6}, pages={391-6}}"}}, {"_id": "15575340", "pmid": 15575340, "title": "Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.", "journal": "Diabetes Nutr Metab", "authors": ["Ceylan A", "Karasu C", "Aktan F", "Ozansoy G"], "date": "2004-08-01T00:00:00Z", "meta_date_publication": "2004 Aug", "meta_volume": "17", "meta_issue": "4", "meta_pages": "203-10", "score": 50049.426, "text_hl": "Plasma @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@, @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglyceride@@@ and total @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ concentrations were significantly increased in 12-week @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment stopped the @<m>DISEASE_Body_Weight</m> @DISEASE_MESH:D001835 @@@loss of body weight@@@, completely normalized the increase of plasma @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@ and partially reduced the hyperglycaemia in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Ceylan A, Karasu C, Aktan F, Ozansoy G. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats. Diabetes Nutr Metab. 2004 Aug;17(4):203-10. PMID: 15575340", "BibTeX": "@article{15575340, title={Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.}, author={Ceylan A and Karasu C and Aktan F and Ozansoy G}, journal={Diabetes Nutr Metab}, volume={17}, number={4}, pages={203-10}}"}}, {"_id": "10465354", "pmid": 10465354, "title": "Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet.", "journal": "Life Sci", "authors": ["Díaz-Zagoya JC", "Asenjo-Barrón JC", "Cárdenas-Vázquez R", "Martínez F", "Juárez-Oropeza MA"], "date": "1999-01-01T00:00:00Z", "doi": "10.1016/s0024-3205(99)00324-0", "meta_date_publication": "1999", "meta_volume": "65", "meta_issue": "9", "meta_pages": "947-56", "score": 50049.05, "text_hl": "In the experiment with high doses of VTS + CD, the animals receiving @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SVT@@@ or @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@FVT@@@ showed a moderate @<m>DISEASE_Body_Weight</m> @DISEASE_MESH:D001835 @@@loss of body weight@@@. ", "citations": {"NLM": "Díaz-Zagoya JC, Asenjo-Barrón JC, Cárdenas-Vázquez R, Martínez F, Juárez-Oropeza MA. Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet. Life Sci. 1999;65(9):947-56. PMID: 10465354", "BibTeX": "@article{10465354, title={Comparative toxicity of high doses of vastatins currently used by clinicians, in CD-1 male mice fed with a hypercholesterolemic diet.}, author={Díaz-Zagoya JC and Asenjo-Barrón JC and Cárdenas-Vázquez R and Martínez F and Juárez-Oropeza MA}, journal={Life Sci}, volume={65}, number={9}, pages={947-56}}"}}, {"_id": "1904494", "pmid": 1904494, "title": "HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.", "journal": "J Pharmacol Exp Ther", "authors": ["Smith PF", "Eydelloth RS", "Grossman SJ", "Stubbs RJ", "Schwartz MS", "Germershausen JI", "Vyas KP", "Kari PH", "MacDonald JS"], "date": "1991-06-01T00:00:00Z", "meta_date_publication": "1991 Jun", "meta_volume": "257", "meta_issue": "3", "meta_pages": "1225-35", "score": 50028.375, "text_hl": "Physical signs included inappetence, decreased activity, @<m>DISEASE_Body_Weight</m> @DISEASE_MESH:D001835 @@@loss of body weight@@@, localized @DISEASE_Alopecia @DISEASE_MESH:D000505 @@@alopecia@@@ and mortality. ", "citations": {"NLM": "Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35. PMID: 1904494", "BibTeX": "@article{1904494, title={HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.}, author={Smith PF and Eydelloth RS and Grossman SJ and Stubbs RJ and Schwartz MS and Germershausen JI and Vyas KP and Kari PH and MacDonald JS}, journal={J Pharmacol Exp Ther}, volume={257}, number={3}, pages={1225-35}}"}}]}